- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Daclatasvir – November 2015
Daclatasvir: tablet, 60mg or 30mg, Daklinza®
Last updated
4 March 2016